From a basic to a functional approach for developing a blood stage vaccine against Plasmodium vivax
Introduction: Numerous challenges have hampered developing an anti-malarial vaccine against the most widespread malarial parasite worldwide: Plasmodium vivax. Despite the progress achieved in studying proteins in short-term in vitro culture or in experimental models, there is still no clear method f...
- Autores:
- Tipo de recurso:
- Fecha de publicación:
- 2020
- Institución:
- Universidad del Rosario
- Repositorio:
- Repositorio EdocUR - U. Rosario
- Idioma:
- eng
- OAI Identifier:
- oai:repository.urosario.edu.co:10336/24050
- Acceso en línea:
- https://doi.org/10.1080/14760584.2020.1733421
https://repository.urosario.edu.co/handle/10336/24050
- Palabra clave:
- Epitope
Protozoal protein
Protozoal vaccine
Antigenicity
Cell interaction
Dna polymorphism
Jk-1 cell line
Nonhuman
Plasmodium vivax
Platyrrhini
Priority journal
Protein function
Protein interaction
Reticulocyte
Reverse genetics
Review
In vitro culture
Malaria
Plasmodium vivax
Protective immune response
Receptor-ligand interaction
Vaccine
- Rights
- License
- Abierto (Texto Completo)
id |
EDOCUR2_fae33d0d2eaa2a1c2f14c53a034e8cf6 |
---|---|
oai_identifier_str |
oai:repository.urosario.edu.co:10336/24050 |
network_acronym_str |
EDOCUR2 |
network_name_str |
Repositorio EdocUR - U. Rosario |
repository_id_str |
|
spelling |
79653065600eca483d3-a229-42c8-8a6d-3b5e6f002e5b-14138d92d-a7e8-46a5-b415-2d76a4bb9f23-12020-05-26T00:08:02Z2020-05-26T00:08:02Z2020Introduction: Numerous challenges have hampered developing an anti-malarial vaccine against the most widespread malarial parasite worldwide: Plasmodium vivax. Despite the progress achieved in studying proteins in short-term in vitro culture or in experimental models, there is still no clear method for defining which antigens or their regions should be prioritized for including them in a vaccine. Areas covered: The methods used by research groups so far which have focused on the functional analysis of P. vivax blood stage antigens have been reviewed here. A logical strategy orientated toward resolving two of the most commonly occurring problems in designing vaccines against this species has thus been proposed (i.e. the search for candidates and evaluating/ascertaining their functional role in the invasion of such molecules). Expert commentary: Advances in knowledge regarding P. vivax biology have been extremely slow. Only two key receptor–ligand interactions concerning merozoite entry to reticulocytes have been reported during the last 20 years: PvDBP1-DARC and PvRBP2b-CD71. Despite increasing knowledge about the parasite’s intimate preference for its host cells, it has yet to be determined which regions of the merozoite molecules characterized to date meet the requirement of inducing protective immune responses effectively blocking heterologous parasite entry to human cells. © 2020, © 2020 Informa UK Limited, trading as Taylor and Francis Group.application/pdfhttps://doi.org/10.1080/14760584.2020.173342114760584https://repository.urosario.edu.co/handle/10336/24050engTaylor and Francis Ltd207No. 2195Expert Review of VaccinesVol. 19Expert Review of Vaccines, ISSN:14760584, Vol.19, No.2 (2020); pp. 195-207https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080136022&doi=10.1080%2f14760584.2020.1733421&partnerID=40&md5=62d006e8d895475d3936104ab684bee4Abierto (Texto Completo)http://purl.org/coar/access_right/c_abf2instname:Universidad del Rosarioreponame:Repositorio Institucional EdocUREpitopeProtozoal proteinProtozoal vaccineAntigenicityCell interactionDna polymorphismJk-1 cell lineNonhumanPlasmodium vivaxPlatyrrhiniPriority journalProtein functionProtein interactionReticulocyteReverse geneticsReviewIn vitro cultureMalariaPlasmodium vivaxProtective immune responseReceptor-ligand interactionVaccineFrom a basic to a functional approach for developing a blood stage vaccine against Plasmodium vivaxarticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Patarroyo, Manuel A.Arévalo-Pinzón, GabrielaMoreno-Pérez, Darwin A10336/24050oai:repository.urosario.edu.co:10336/240502022-05-02 07:37:21.37173https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co |
dc.title.spa.fl_str_mv |
From a basic to a functional approach for developing a blood stage vaccine against Plasmodium vivax |
title |
From a basic to a functional approach for developing a blood stage vaccine against Plasmodium vivax |
spellingShingle |
From a basic to a functional approach for developing a blood stage vaccine against Plasmodium vivax Epitope Protozoal protein Protozoal vaccine Antigenicity Cell interaction Dna polymorphism Jk-1 cell line Nonhuman Plasmodium vivax Platyrrhini Priority journal Protein function Protein interaction Reticulocyte Reverse genetics Review In vitro culture Malaria Plasmodium vivax Protective immune response Receptor-ligand interaction Vaccine |
title_short |
From a basic to a functional approach for developing a blood stage vaccine against Plasmodium vivax |
title_full |
From a basic to a functional approach for developing a blood stage vaccine against Plasmodium vivax |
title_fullStr |
From a basic to a functional approach for developing a blood stage vaccine against Plasmodium vivax |
title_full_unstemmed |
From a basic to a functional approach for developing a blood stage vaccine against Plasmodium vivax |
title_sort |
From a basic to a functional approach for developing a blood stage vaccine against Plasmodium vivax |
dc.subject.keyword.spa.fl_str_mv |
Epitope Protozoal protein Protozoal vaccine Antigenicity Cell interaction Dna polymorphism Jk-1 cell line Nonhuman Plasmodium vivax Platyrrhini Priority journal Protein function Protein interaction Reticulocyte Reverse genetics Review In vitro culture Malaria Plasmodium vivax Protective immune response Receptor-ligand interaction Vaccine |
topic |
Epitope Protozoal protein Protozoal vaccine Antigenicity Cell interaction Dna polymorphism Jk-1 cell line Nonhuman Plasmodium vivax Platyrrhini Priority journal Protein function Protein interaction Reticulocyte Reverse genetics Review In vitro culture Malaria Plasmodium vivax Protective immune response Receptor-ligand interaction Vaccine |
description |
Introduction: Numerous challenges have hampered developing an anti-malarial vaccine against the most widespread malarial parasite worldwide: Plasmodium vivax. Despite the progress achieved in studying proteins in short-term in vitro culture or in experimental models, there is still no clear method for defining which antigens or their regions should be prioritized for including them in a vaccine. Areas covered: The methods used by research groups so far which have focused on the functional analysis of P. vivax blood stage antigens have been reviewed here. A logical strategy orientated toward resolving two of the most commonly occurring problems in designing vaccines against this species has thus been proposed (i.e. the search for candidates and evaluating/ascertaining their functional role in the invasion of such molecules). Expert commentary: Advances in knowledge regarding P. vivax biology have been extremely slow. Only two key receptor–ligand interactions concerning merozoite entry to reticulocytes have been reported during the last 20 years: PvDBP1-DARC and PvRBP2b-CD71. Despite increasing knowledge about the parasite’s intimate preference for its host cells, it has yet to be determined which regions of the merozoite molecules characterized to date meet the requirement of inducing protective immune responses effectively blocking heterologous parasite entry to human cells. © 2020, © 2020 Informa UK Limited, trading as Taylor and Francis Group. |
publishDate |
2020 |
dc.date.accessioned.none.fl_str_mv |
2020-05-26T00:08:02Z |
dc.date.available.none.fl_str_mv |
2020-05-26T00:08:02Z |
dc.date.created.spa.fl_str_mv |
2020 |
dc.type.eng.fl_str_mv |
article |
dc.type.coarversion.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_6501 |
dc.type.spa.spa.fl_str_mv |
Artículo |
dc.identifier.doi.none.fl_str_mv |
https://doi.org/10.1080/14760584.2020.1733421 |
dc.identifier.issn.none.fl_str_mv |
14760584 |
dc.identifier.uri.none.fl_str_mv |
https://repository.urosario.edu.co/handle/10336/24050 |
url |
https://doi.org/10.1080/14760584.2020.1733421 https://repository.urosario.edu.co/handle/10336/24050 |
identifier_str_mv |
14760584 |
dc.language.iso.spa.fl_str_mv |
eng |
language |
eng |
dc.relation.citationEndPage.none.fl_str_mv |
207 |
dc.relation.citationIssue.none.fl_str_mv |
No. 2 |
dc.relation.citationStartPage.none.fl_str_mv |
195 |
dc.relation.citationTitle.none.fl_str_mv |
Expert Review of Vaccines |
dc.relation.citationVolume.none.fl_str_mv |
Vol. 19 |
dc.relation.ispartof.spa.fl_str_mv |
Expert Review of Vaccines, ISSN:14760584, Vol.19, No.2 (2020); pp. 195-207 |
dc.relation.uri.spa.fl_str_mv |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080136022&doi=10.1080%2f14760584.2020.1733421&partnerID=40&md5=62d006e8d895475d3936104ab684bee4 |
dc.rights.coar.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
dc.rights.acceso.spa.fl_str_mv |
Abierto (Texto Completo) |
rights_invalid_str_mv |
Abierto (Texto Completo) http://purl.org/coar/access_right/c_abf2 |
dc.format.mimetype.none.fl_str_mv |
application/pdf |
dc.publisher.spa.fl_str_mv |
Taylor and Francis Ltd |
institution |
Universidad del Rosario |
dc.source.instname.spa.fl_str_mv |
instname:Universidad del Rosario |
dc.source.reponame.spa.fl_str_mv |
reponame:Repositorio Institucional EdocUR |
repository.name.fl_str_mv |
Repositorio institucional EdocUR |
repository.mail.fl_str_mv |
edocur@urosario.edu.co |
_version_ |
1814167459883646976 |